
Equitable Access to Medicines Across Europe: The Role of Digital Solutions
Date
Address
Links
Organiser type
Section
Event Location
Event Description
Access to medicines is a fundamental right enshrined in European and global health policies. Despite significant advancements in healthcare across Europe, disparities in availability and accessibility of medicines persist, disproportionately affecting vulnerable populations and remote/rural regions. These disparities have been further exposed during the COVID-19 pandemic, highlighting systemic challenges in supply chains and healthcare infrastructure. Digital health solutions present a transformative opportunity to bridge these gaps.
The possibility for patients across Europe to access digital health services, such as remote consultations or online order and home delivery of medicines, can enhance availability and accessibility of medicines, as well as transparency of prices, thus fostering equitable access to healthcare in all countries. These are well-established practices in 8 EU Member States: Sweden, Germany, Netherlands, Denmark, Finland, Portugal, Lithuania, and Estonia all enable their patients to make full use of these innovative solutions. However, realising the potential of digital solutions for all patients in Europe requires a harmonised policy framework, cross-border collaboration, and breaking the barriers that still stifle their adoption.
This event, hosted by MEP Kristian Vigenin (S&D, Bulgaria) in collaboration with the OnHOME Alliance, aims to foster dialogue among policymakers, healthcare professionals, patient representatives, and industry stakeholders on advancing equitable access to medicines through digital innovation. The ongoing revision of the General Pharmaceutical Legislation (GPL) provides a once in a generation opportunity to address inequitable patient access, address medicine shortages, and to empower healthcare providers across all Member States to offer additional patient services through digitalisation and innovative means.
Save your spot now by registering here!
Related Events
“European policy response to rare cancers: the case of sarcoma”
8th February 2017, 14h30-16h30
European Parliament, Altiero Spinelli building, room A5E-2, Brussels
Preventing sight loss in an ageing population
The role of screening and early diagnosis in identifying eye diseases as comorbidities of non-communicable diseases
Cancer clinical trials and, in general, cancer clinical research are, by definition, multi-modal disciplines.
Policy Debate
Organised by the European Academy of Dermatology and Venereology
ECPC wants to contribute to raise awareness about bladder cancer. The White Paper to be launched on 20 April 2016 is an appeal to policy makers, the scientific and medical community to reduce the burden of bladder cancer on patients.
The SESEC Conference in Brussels will give an insight on the next policy developments on Energy Efficiency, the energy cost evolutions and ready-to-use project results for the textile and clothing industry.
The Neuromed-led project "Neurobiotech”, aims at setting up an International Research and Innovation Community on Neuroscience.
European standardization in the healthcare sector has traditionally been limited to medical devices and e-health applications. Nevertheless, in recent years there has been an increasing level of demand from stakeholders in relation to the standardization of healthcare services.
ANEC - the European Voice in Standardization, the Austrian Standards Institute Consumer Council in co-operation with Austrian Ministry of Health (BMG), Austrian Ministry of Labour, Social Affairs and Consumer Protection (BMASK), Belgium Public Service (FPS) Health, Food Chain Safety and E
Head and neck cancer is the 6th most common type of cancer in Europe with more than 150,000 new patients diagnosed in 2012, and the incidence of the disease is on the rise.
On 17 September, THE even on obesity is taking place in Brussels, This high-level event will gather eminent scientists and policy makers to discuss how to encounter the obesity epidemic in Europe.
Highlights of the day:
Privatization of Public Goods
26 June 2013, 15.00-18.30,European Parliament, Room ASP A1G2
PROGRAMME
15.00 – 15.15 Opening
Gabi Zimmer, President GUE/NGL
Thomas Händel, MEP GUE/NGL , (Die Linke, Germany)
The Protected Geographical Indication Pays d'Oc wines, the varietal wines French leader with an annual production of more than 6 millions of hectolitres, wish to gather and federate, around the concept of the wine under quality labels, the actors of theMediterranean regions of Europewho share wit
COST is a partner of the inaugural World Research and Innovation Congress - Pioneers In Healthcare.
The Greens/EFA group in the European Parliament invites you to a conference on "How GMO-free labelling of food products can contribute to increase GMO-free supplies for animal feed", co-hosted by MEPs José Bové, Jill Evans and Bart Staes.
In celebration of World Kidney Day, the European Kidney Health Alliance is delighted to invite you to its luncheon event, organised in collaboration with the MEP Group for Kidney Health on 5 March 2013.